EPIRUS Biopharmaceuticals, Inc. announced that Mr. Amit Munshi, the company's President and Chief Executive Officer and a member of its Board of Directors has resigned from each of those positions. On May 6, 2016, the Board appointed Scott Rocklage, Ph.D., a current member of the Board, as the Company's acting Chief Executive Officer. On May 6, 2016, the Board appointed Michael Wyand, DVM, Ph.D., as the Company's President and Chief Operating Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 26 | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- EPRSQ Stock
- News EPIRUS Biopharmaceuticals, Inc.
- EPIRUS Biopharmaceuticals, Inc. Announces Executive Changes